Products/Services Used | Details | Operation |
---|---|---|
PCR Cloning and Subcloning> | … Fortress Biotech, Pharmacyclics; has received honoraria from BMS, AstraZeneca, Chugai Pharma … by Genscript and sequence verified (Piscataway Township, NJ) … 1:500), beta-actin (C4; sc-47778; 1: 10,000) from Santa Cruz Biotechnology, V5/HRP (R961-25; … | Get A Quote |
Focal amplification of chromosome 1q23.3 in patients with advanced primary or relapsed urothelial carcinomas is associated with poor survival. We interrogated chromosome 1q23.3 and the nearby focal amplicon 1q21.3, as both are associated with increased lymph node disease in patients with urothelial carcinoma. Specifically, we assessed whether the oncogene that resides in 1q21.3 and the genes that reside in the 1q23.3 amplicon were required for the proliferation or survival of urothelial carcinoma. We observed that suppressing MCL1 or the death effector domain-containing protein (DEDD) in the cells that harbor amplifications of 1q21.3 or 1q23.3, respectively, inhibited cell proliferation. We also found ... More